Physician profile
Peter G Aline
NPI 1033296207
$863.69
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $183 · 2020: $72.60 · 2021: $214 · 2022: $154 · 2023: $193 · 2024: $46.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $239.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $239.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $273.80 | 2019-2023 | |
| Acadia Pharmaceuticals INC | $143.14 | 2019-2023 | Nuplazid |
| Otsuka America Pharmaceutical, INC. | $115.49 | 2023-2024 | Rexulti |
| Astrazeneca Pharmaceuticals LP | $106.21 | 2021 | |
| Janssen Pharmaceuticals, INC | $59.81 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $42.59 | 2021-2022 | |
| Pfizer INC. | $32.19 | 2021 | |
| Amgen INC. | $26.85 | 2024 | Prolia, Evenity |
| Sk Life Science, INC. | $22.96 | 2022 | |
| Almatica Pharma LLC | $15.97 | 2023 | Loreev Xr, Sertraline Hcl, Gralise |
| Avanir Pharmaceuticals, INC. | $12.59 | 2019 | |
| Lilly USA, LLC | $12.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Aline listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.